Kangmei Pharmaceutical Co (SHSE:600518) Other Long-Term Liabilities : ¥2,300 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Kangmei Pharmaceutical Co Other Long-Term Liabilities?

Kangmei Pharmaceutical Co's other long-term liabilities for the quarter that ended in Mar. 2024 was ¥2,300 Mil.

Kangmei Pharmaceutical Co's quarterly other long-term liabilities declined from Sep. 2023 (¥2,385 Mil) to Dec. 2023 (¥2,332 Mil) and declined from Dec. 2023 (¥2,332 Mil) to Mar. 2024 (¥2,300 Mil).

Kangmei Pharmaceutical Co's annual other long-term liabilities increased from Dec. 2021 (¥986 Mil) to Dec. 2022 (¥2,544 Mil) but then declined from Dec. 2022 (¥2,544 Mil) to Dec. 2023 (¥2,332 Mil).

Kangmei Pharmaceutical Co Other Long-Term Liabilities Historical Data

The historical data trend for Kangmei Pharmaceutical Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangmei Pharmaceutical Co Other Long-Term Liabilities Chart

Kangmei Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Kangmei Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Kangmei Pharmaceutical Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Kangmei Pharmaceutical Co Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Kangmei Pharmaceutical Co's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Kangmei Pharmaceutical Co (SHSE:600518) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kangmei Pharmaceutical Co Ltd (SHSE:600518) » Definitions » Other Long-Term Liabilities

Traded in Other Exchanges

N/A

Address

No. 3, Taike Road, Xiameilin, Futian District, Shenzhen, CHN, 518000

Website

http://www.kangmei.com.cn

Kangmei Pharmaceutical Co Ltd is a pharmaceutical company engaged in the manufacturing, research and marketing of herbal medicine and chemical raw materials.

Executives

Xu Dong Jin	Director
Li Jian Hua	senior management
Qiu Xi Wei	Director
Wang Min	senior management
Peng Qin	senior management
Ma Xing Tian	Director
Lin Guo Xiong	senior management
Zhuang Yi Qing	senior management
Wen Shao Sheng	Supervisors

Kangmei Pharmaceutical Co (SHSE:600518) Headlines

No Headlines